CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 25 enrolled
Drug / intervention
Adapalene Gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00714714
NCT00714714Phase 4Completed
CompareCT.gov

An Investigator-Blind, Phase 4 Study Assessing the Facial Irritation Potential of Two Acne Treatment Products Using a Split-Face Model

Bausch Health Americas, Inc.·interventional·Posted Jul 14, 2008·Updated Feb 15, 2012

In Brief

A Phase 4 clinical trial evaluating Adapalene Gel and Tretinoin Gel for Acne Vulgaris. Completed, enrolled 25 participants across 1 site.

Detailed Summary

A study to compare the skin irritation potential of two marketed gels for acne treatment, each applied to half of the face of healthy volunteers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 14, 2008
Enrollment StartJan 1, 2008
Primary CompletionFeb 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 18.0 years ago

Interventions

Adapalene Geldrug

adapalene gel 0.3% topically applied daily in a split-face model for two weeks

Tretinoin Geldrug

Tretinoin 0.1% topically applied daily in a split face model for two weeks